Botanix Pharmaceuticals Limited (ASX:BOT)
0.0530
-0.0010 (-1.85%)
Mar 10, 2026, 1:41 PM AEST
Botanix Pharmaceuticals Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Cash & Equivalents | 31.61 | 64.97 | 79.31 | 10.25 | 7.29 | 21.55 | Upgrade
|
| Cash & Short-Term Investments | 31.61 | 64.97 | 79.31 | 10.25 | 7.29 | 21.55 | Upgrade
|
| Cash Growth | -34.73% | -18.08% | 673.71% | 40.69% | -66.20% | -12.54% | Upgrade
|
| Accounts Receivable | 5.7 | 2.85 | 0.46 | 0.4 | - | - | Upgrade
|
| Other Receivables | - | 0.35 | 0.36 | 0.09 | 0.14 | 0.05 | Upgrade
|
| Receivables | 5.7 | 3.2 | 0.82 | 0.49 | 0.14 | 0.05 | Upgrade
|
| Inventory | 27.51 | 28.08 | 1.21 | 3.15 | 3.04 | - | Upgrade
|
| Prepaid Expenses | 5.91 | 3.34 | 0.1 | 0.09 | 0.03 | 0.01 | Upgrade
|
| Other Current Assets | - | - | 1.47 | - | - | - | Upgrade
|
| Total Current Assets | 70.74 | 99.59 | 82.9 | 13.98 | 10.5 | 21.61 | Upgrade
|
| Property, Plant & Equipment | 1.13 | 1.38 | 0.07 | 0.07 | 0.18 | 0.28 | Upgrade
|
| Other Intangible Assets | 26.71 | 28.12 | 29.49 | 6.86 | 3.3 | - | Upgrade
|
| Long-Term Deferred Charges | - | - | - | 3.87 | - | - | Upgrade
|
| Other Long-Term Assets | - | - | - | 0.06 | 0.06 | 0.06 | Upgrade
|
| Total Assets | 98.57 | 129.1 | 112.46 | 24.84 | 14.04 | 21.95 | Upgrade
|
| Accounts Payable | 7 | 8.87 | 2.73 | 1.39 | 4.68 | 0.65 | Upgrade
|
| Accrued Expenses | 4.28 | 3.94 | 0.56 | 0.15 | 0.1 | 0.09 | Upgrade
|
| Current Portion of Leases | 0.46 | 0.41 | - | - | 0.12 | 0.15 | Upgrade
|
| Other Current Liabilities | 15.93 | 11.7 | 0.44 | 0.34 | 0.99 | 0.15 | Upgrade
|
| Total Current Liabilities | 27.66 | 24.92 | 3.73 | 1.88 | 5.89 | 1.04 | Upgrade
|
| Long-Term Leases | 0.62 | 0.81 | - | - | - | 0.11 | Upgrade
|
| Other Long-Term Liabilities | 16.29 | 22.07 | - | - | - | - | Upgrade
|
| Total Liabilities | 44.58 | 47.8 | 3.73 | 1.88 | 5.89 | 1.15 | Upgrade
|
| Common Stock | 226.32 | 226.3 | 188.32 | 93.49 | 71.48 | 71.48 | Upgrade
|
| Retained Earnings | -210.38 | -177.19 | -90.79 | -76.92 | -67.77 | -54.6 | Upgrade
|
| Comprehensive Income & Other | 38.06 | 32.18 | 11.2 | 6.38 | 4.44 | 3.92 | Upgrade
|
| Shareholders' Equity | 54 | 81.3 | 108.73 | 22.95 | 8.15 | 20.8 | Upgrade
|
| Total Liabilities & Equity | 98.57 | 129.1 | 112.46 | 24.84 | 14.04 | 21.95 | Upgrade
|
| Total Debt | 1.08 | 1.22 | - | - | 0.12 | 0.26 | Upgrade
|
| Net Cash (Debt) | 30.53 | 63.75 | 79.31 | 10.25 | 7.16 | 21.3 | Upgrade
|
| Net Cash Growth | -35.81% | -19.62% | 673.71% | 43.10% | -66.36% | -12.09% | Upgrade
|
| Net Cash Per Share | 0.02 | 0.03 | 0.05 | 0.01 | 0.01 | 0.02 | Upgrade
|
| Filing Date Shares Outstanding | 1,968 | 1,961 | 1,814 | 1,421 | 1,085 | 973.14 | Upgrade
|
| Total Common Shares Outstanding | 1,968 | 1,961 | 1,810 | 1,312 | 973.14 | 973.14 | Upgrade
|
| Working Capital | 43.08 | 74.67 | 79.17 | 12.09 | 4.62 | 20.57 | Upgrade
|
| Book Value Per Share | 0.03 | 0.04 | 0.06 | 0.02 | 0.01 | 0.02 | Upgrade
|
| Tangible Book Value | 27.29 | 53.17 | 79.24 | 16.1 | 4.86 | 20.8 | Upgrade
|
| Tangible Book Value Per Share | 0.01 | 0.03 | 0.04 | 0.01 | 0.00 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.